Integrated Biopharma Inc's Comment on Supply Chain
The Company sources raw materials and products from principal suppliers, including DSM Nutritional Products LLC. It has development and supply agreements with Herbalife International of America, Inc. and Herbalife International of Luxembourg S.à.R.L., subsidiaries of Herbalife, to develop, manufacture, and supply certain nutritional products. These agreements are effective from December 31, 2023, through December 31, 2025, and do not require minimum order quantities. The Company also enters into similar agreements with other customers in its contract manufacturing business. Although the nutraceutical business can be seasonal, the Company has not recently experienced seasonality impacts due to its current customer base. Manufacturing and product activities are regulated by federal agencies including the FDA, FTC, United States Postal Service, Consumer Product Safety Commission, and USDA, as well as state and local agencies. The FDA regulates the manufacturing facility as a dietary supplement manufacturing facility, while advertising claims are regulated by the USPS and FTC. The Company complies with guidelines from the United States Pharmacopoeia Convention, Inc. and other voluntary standards organizations. It follows the regulatory framework established by the Dietary Supplement Health and Education Act of 1994.
Integrated Biopharma Inc's Comment on Supply Chain
The Company sources raw materials and products from principal suppliers, including DSM Nutritional Products LLC. It has development and supply agreements with Herbalife International of America, Inc. and Herbalife International of Luxembourg S.à.R.L., subsidiaries of Herbalife, to develop, manufacture, and supply certain nutritional products. These agreements are effective from December 31, 2023, through December 31, 2025, and do not require minimum order quantities. The Company also enters into similar agreements with other customers in its contract manufacturing business. Although the nutraceutical business can be seasonal, the Company has not recently experienced seasonality impacts due to its current customer base. Manufacturing and product activities are regulated by federal agencies including the FDA, FTC, United States Postal Service, Consumer Product Safety Commission, and USDA, as well as state and local agencies. The FDA regulates the manufacturing facility as a dietary supplement manufacturing facility, while advertising claims are regulated by the USPS and FTC. The Company complies with guidelines from the United States Pharmacopoeia Convention, Inc. and other voluntary standards organizations. It follows the regulatory framework established by the Dietary Supplement Health and Education Act of 1994.
Sources:
Integrated Biopharma Inc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Integrated Biopharma Inc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
